Comparison of Two Strategies for Prophylactic Donor Lymphocyte Infusion in Patients With Refractory/Relapsed Acute Leukemia

Prophylactic donor lymphocyte infusion (pDLI) could reduce relapse in patients with refractory/relapsed acute leukemia (RRAL) undergoing allogeneic hematopoietic stem cell transplantation (allo-HSCT), but optimal timing of pDLI remains uncertain. We compared the outcomes of two strategies for pDLI b...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Front Oncol
Main Authors: Su, Qiongqiong, Fan, Zhiping, Huang, Fen, Xu, Na, Nie, Danian, Lin, Dongjun, Guo, Ziwen, Shi, Pengcheng, Wang, Zhixiang, Jiang, Ling, Sun, Jing, Jiang, Zujun, Liu, Qifa, Xuan, Li
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2021
Assuntos:
Oncology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7966710/
https://ncbi.nlm.nih.gov/pubmed/33747904
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2021.554503
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados